Attention and Activity Did Not Change Together in a Medicinal-Cannabis Tourette Case
A Tourette syndrome case report described better attention on the cannabis-use day without a matching normalization of activity or impulsivity scores. A favorable result in one ADHD domain should not be presented as a complete response across all domains.
The assessment separated symptom components
Streetz and colleagues used a computerized Quantified Behavior test in one man with Tourette syndrome and ADHD. The table reports activity, impulsivity and attention separately on two days. Activity and impulsivity scores remained elevated and were similar between assessments.
Attention showed a different pattern
The attention score was more favorable on the day with cannabis intake than on the following day without additional intake before testing. The report therefore contains a domain-specific observation rather than evidence that all ADHD features resolved. It is also not a controlled test demonstrating that cannabis caused the difference.
The comparison was not an untreated randomized trial
The patient had a long cannabis-treatment history, residual serum THC on the second day and fixed-order assessments. Day-to-day variation, symptom burden and other factors could contribute. The computerized scores do not establish sustained benefit at work or on the road. The case can motivate research into symptom-specific effects, but cannot establish clinical efficacy or a treatment regimen for people with ADHD. Keeping attention separate from activity and impulsivity preserves the actual finding without inflating one favorable score into a comprehensive therapeutic conclusion.
Related analysis: the serum THC and driving-related findings in this case.
Research cited
Streetz and colleagues. Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD. Frontiers in Psychiatry (2025). DOI: 10.3389/fpsyt.2025.1595649.
